Regency Capital Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
2024
Q1
$4.86M Buy
2023
Q4
$3.7M Buy
2022
Q1
Sell
2021
Q4
$300K Sell
2021
Q3
$793K Sell
2021
Q2
$2.16M Buy
2021
Q1
$1.49M Buy